US TAA strategies for EU investors: how clean is the UCITS substitution actually?
Question for the people here who run tactical asset allocation from a European broker.
I've been trying to set up HAA on IBKR Ireland. The strategy wants nine US-listed ETFs (SPY, QQQ, IWM, IEF, TLT, GLD, VWO, VEA, DBC). Eight of those have a clean UCITS substitute on XETRA or LSE. The ninth (DBC, diversified commodity strategy) doesn't, because the active K-1-free wrapper isn't doable under UCITS rules.
That's fine for HAA, where DBC is a small sleeve. But the same pattern repeats across half the popular TAA strategies. Some sleeves substitute cleanly, some don't, and people on these subs tend to either say "just buy VWCE" or hand-wave that UCITS is fine without actually checking which sleeves degrade.
I came across a writeup on bestfolio.app that ranks ~10 well-known TAA strategies by how cleanly their universes translate to UCITS. Tier 1 are the ones that just work (HAA-minus-DBC, GEM, Permanent Portfolio, Dalio All-Weather, 60/40). Tier 2 are the ones where a sleeve loses methodology character (small-cap value: ZPRV is the closest UCITS, but the Avantis profitability tilt is missing; AVWS launched late 2024 if you want the Avantis methodology on a global rather than US-only universe). Tier 3 is where there's no real substitute (active commodity DBC/PDBC, USD-denominated TIPS).
Link: https://bestfolio.app/blog/taa-strategies-europe-ucits-substitution
Two things I'd actually like input on:
What's the cleanest UCITS substitute people here have found for the US TIPS sleeve, ideally EUR-hedged without the 30-50bp hedging drag?
And has anyone backtested the AVUV-vs-AVWS divergence over a real strategy window? I expect global-developed-SCV to bleed maybe 50-100bp annually vs the US-only original on a 15% sleeve, but I haven't seen the actual numbers.